General Information of the Compound
Compound ID
CP0513351
Compound Name
N-[5-bromo-2-(2H-tetrazol-5-yl)phenyl]-3,4-dimethoxybenzamide
    Show/Hide
Structure
Formula
C16H14BrN5O3
Molecular Weight
404.224
Canonical SMILES
COc1ccc(cc1OC)C(=O)Nc1cc(Br)ccc1-c1nnn[nH]1
    Show/Hide
InChI
InChI=1S/C16H14BrN5O3/c1-24-13-6-3-9(7-14(13)25-2)16(23)18-12-8-10(17)4-5-11(12)15-19-21-22-20-15/h3-8H,1-2H3,(H,18,23)(H,19,20,21,22)
    Show/Hide
InChIKey
QTUJYPVWVKRRMB-UHFFFAOYSA-N
Physicochemical Property
logP
2.8987
Rotatable Bonds
5
Heavy Atom Count
25
Polar Areas
102.02
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
6
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 145953203
ChEMBL ID
CHEMBL4167991
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03308, G-protein coupled receptor 35
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000007 HT-29 Homo sapiens (Human)  1
1
IC50 = 260 nM
   TI
   LI
   LO
   TS